American Samoa Community Cancer Coalition
The goal of this study is to learn about ADRD prevalence within the Samoan population. Participants will be administered a series of cognitive assessments to determine cognitive status and a population-based prevalence of Mild Cognitive Impairment (MCI) and ADRD. Blood samples will also be collected from the participants for genetic and plasma biomarker analysis.
Alzheimer's Disease and Related Dementia
This study aims to do the following: Test ADRD knowledge, health literacy, research readiness and determine ADRD resilience and vulnerability factors, and cognitive status in a probability sample of 981 Samoans age 50+ using culturally adapted instruments in our probability sample. Conduct Gold Standard evaluations in our probability sample using the Uniform Data Set (UDSv3.0) from the National Institute on Aging (NIA) Alzheimer's Disease Research Center program to determine a population-based prevalence of MCI and ADRD for harmonization, data sharing, and comparison to other groups, and, Cross-validate Gold Standard dementia evaluations with genetic (i.e., ApoE) and plasma Amyloid-Tau-Neuronal Injury/Neurodegeneration (ATN) framework biomarkers in our probability sample and compare to information available for other racial/ethnic groups.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 1098 participants |
| Official Title : | ADRD Prevalence in American Samoa |
| Actual Study Start Date : | 2022-09-30 |
| Estimated Primary Completion Date : | 2025-09 |
| Estimated Study Completion Date : | 2025-09 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 50 Years |
| Sexes Eligible for Study: | ALL |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Malaloa GHC Reid Building
Payment payment, American Samoa, 96799
RECRUITING
Correct Building
Payment payment, American Samoa, 96799